PARK CITY, Utah, Nov. 6, 2023 /PRNewswire/ -- BlueWind Medical, Ltd., a pioneer in the development and commercialization of a patient centric implantable Tibial NeuroModulation (iTNM) solution for ...

Axonics (NASDAQ:AXNX) said it acquired a lead placement solution from Radian which complements the company's existing sacral neuromodulation (SNM) offering. The company acquired the assets of Radian ...

- This demonstration of a miniature implantable stimulator used in humans could unlock minimally invasive therapies for treatment-resistant neuropsychiatric disorders - Approximately 30% of adults ...

Gastroesophageal reflux disease (GERD) is a prevalent chronic condition characterized by recurrent reflux of stomach contents into the esophagus, leading to troublesome symptoms such as heartburn, ...

Neurolief announced today that the FDA granted approval for its Proliv Rx at-home neuromodulation therapy for treating depression.

The FDA has approved ProlivRx, the first prescription, home-based brain neuromodulation therapy, as an adjunctive treatment ...

CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and ...

We expect free cash flow to improve through the year as the pandemic-driven delays in neuromodulation procedures ease. Cash flow growth should accelerate as we head into 2023. The firm does not pay a ...

The growth of the neuromodulation market is driven majorly by the rising prevalence of neurological disorders, increasing research into expanding the applications of neuromodulation, and awareness on ...